Plant Biochemistry Laboratory, Department of Plant and Environmental Sciences, University of Copenhagen, Thorvaldsensvej 40, 1871, Frederiksberg C, Denmark.
Evolva A/S, Copenhagen, Denmark.
Microb Cell Fact. 2018 Nov 19;17(1):181. doi: 10.1186/s12934-018-1027-3.
Forskolin is a high-value diterpenoid produced exclusively by the Lamiaceae plant Coleus forskohlii. Today forskolin is used pharmaceutically for its adenyl-cyclase activating properties. The limited availability of pure forskolin is currently hindering its full utilization, thus a new environmentally friendly, scalable and sustainable strategy is needed for forskolin production. Recently, the entire biosynthetic pathway leading to forskolin was elucidated. The key steps of the pathway are catalyzed by cytochrome P450 enzymes (CYPs), which have been shown to be the limiting steps of the pathway. Here we study whether protein engineering of the substrate recognition sites (SRSs) of CYPs can improve their efficiency towards forskolin biosynthesis in yeast.
As a proof of concept, we engineered the enzyme responsible for the first putative oxygenation step of the forskolin pathway: the conversion of 13R-manoyl oxide to 11-oxo-13R-manoyl oxide, catalyzed by the CYP76AH15. Four CYP76AH15 variants-engineered in the SRS regions-yielded at least a twofold increase of 11-oxo-13R-manoyl oxide when expressed in yeast cells grown in microtiter plates. The highest titers (5.6-fold increase) were observed with the variant A99I, mutated in the SRS1 region. Double or triple CYP76AH15 mutant variants resulted in additional enzymes with optimized performances. Moreover, in planta CYP76AH15 can synthesize ferruginol from miltiradiene. In this work, we showed that the mutants affecting 11-oxo-13R-manoyl oxide synthesis, do not affect ferruginol production, and vice versa. The best performing variant, A99I, was utilized to reconstruct the forskolin biosynthetic pathway in yeast cells. Although these strains showed increased 11-oxo-manoyl oxide production and higher accumulation of other pathway intermediates compared to the native CYP76AH15, lower production of forskolin was observed.
As demonstrated for CYP76AH15, site-directed mutagenesis of SRS regions of plant CYPs may be an efficient and targeted approach to increase the performance of these enzymes. Although in this work we have managed to achieve higher efficiency and specificity of the first CYP of the pathway, further work is necessary in order to increase the overall production of forskolin in yeast cells.
毛喉鞘蕊花是唇形科鞘蕊花属植物,是一种高附加值的二萜类化合物,其唯一来源。毛喉鞘蕊花提取物中的有效成分毛喉素具有松弛平滑肌、降低血压等作用,因此在临床上主要用于治疗支气管哮喘和高血压等疾病。由于毛喉鞘蕊花资源稀缺,其含量极低,因此目前的主要问题是需要开发一种新的、环境友好的、可扩展的和可持续的方法来提高毛喉素的产量。
作为概念验证,我们对负责毛喉素生物合成途径中第一个假定加氧步骤的酶进行了工程改造:由 CYP76AH15 催化的 13R- 曼酰氧化物转化为 11- 氧代-13R- 曼酰氧化物。当在微滴定板中生长的酵母细胞中表达时,在 SRS 区域工程改造的四种 CYP76AH15 变体——在 SRS 区域中进行了工程改造——至少产生了 11- 氧代-13R- 曼酰氧化物的两倍增加。在 SRS1 区域突变的 A99I 变体观察到最高的滴度(增加 5.6 倍)。双或三倍 CYP76AH15 突变变体导致具有优化性能的额外酶。此外,体内 CYP76AH15 可以从千里光二烯合成 ferruginol。在这项工作中,我们表明影响 11- 氧代-13R- 曼酰氧化物合成的突变体不会影响 ferruginol 的产生,反之亦然。表现最好的变体 A99I 被用于在酵母细胞中重建毛喉素生物合成途径。尽管与天然 CYP76AH15 相比,这些菌株显示出 11- 氧代- 曼酰氧化物产量增加和其他途径中间体积累增加,但观察到毛喉素产量较低。
正如 CYP76AH15 所证明的那样,植物 CYP 的 SRS 区域的定点突变可能是提高这些酶的性能的有效和有针对性的方法。尽管在这项工作中,我们已经设法提高了途径中的第一个 CYP 的效率和特异性,但仍需要进一步的工作来提高酵母细胞中毛喉素的总产量。